Veraxa Biotech Holding AG (VRXA) Payables (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Payables of $3.0 million for Q4 2025, up 436.41% year-over-year from $557682.5 in Q4 2024, and up 436.41% quarter-over-quarter from $557682.5 in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Payables (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Payables for 2 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables rose 436.41% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 436.41% YoY), while the FY2025 annual figure was $3.0 million, up 436.41% from the prior year.
- Payables climbed to $3.0 million in Q4 2025 per VRXA's latest filing, from $557682.5 in the prior quarter.
- Across five years, Payables topped out at $3.0 million in Q4 2025 and bottomed at $557682.5 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 557,682.51 |